| Louisa Gayle Chavez, MD | |
|
203 Hospital Dr, Raton, NM 87740-2012 | |
| (575) 445-3661 | |
| Not Available |
| Full Name | Louisa Gayle Chavez |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 37 Years |
| Location | 203 Hospital Dr, Raton, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508843293 | NPI | - | NPPES |
| 53856 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 9118 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Health Horizons, Inc | 7618137498 | 7 |
News Archive
After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.
The continuous improvement of imaging technology holds great promise in areas where visual detection is necessary, such as with cancer screening. Three-dimensional imaging in particular has become popular because it provides a more complete picture of the target object and its context.
New research from Johns Hopkins suggests that it may not be the steroids in spinal shots that provide relief from lower back pain, but the mere introduction of any of a number of fluids, such as anesthetics and saline, to the space around the spinal cord.
Medicaid costs for a child's trip to an emergency room or clinic can be reduced annually by at least $198 per family when Head Start parents are provided with easy-to-understand health-care guidance, according to a first-of-its kind study by the UCLA/Johnson & Johnson Health Care Institute.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.
› Verified 7 days ago
| Entity Name | Miners' Colfax Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083931109 PECOS PAC ID: 5294647400 Enrollment ID: O20031105000106 |
News Archive
After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.
The continuous improvement of imaging technology holds great promise in areas where visual detection is necessary, such as with cancer screening. Three-dimensional imaging in particular has become popular because it provides a more complete picture of the target object and its context.
New research from Johns Hopkins suggests that it may not be the steroids in spinal shots that provide relief from lower back pain, but the mere introduction of any of a number of fluids, such as anesthetics and saline, to the space around the spinal cord.
Medicaid costs for a child's trip to an emergency room or clinic can be reduced annually by at least $198 per family when Head Start parents are provided with easy-to-understand health-care guidance, according to a first-of-its kind study by the UCLA/Johnson & Johnson Health Care Institute.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.
› Verified 7 days ago
| Entity Name | Womens Health Horizons, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912181603 PECOS PAC ID: 7618137498 Enrollment ID: O20120402000618 |
News Archive
After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.
The continuous improvement of imaging technology holds great promise in areas where visual detection is necessary, such as with cancer screening. Three-dimensional imaging in particular has become popular because it provides a more complete picture of the target object and its context.
New research from Johns Hopkins suggests that it may not be the steroids in spinal shots that provide relief from lower back pain, but the mere introduction of any of a number of fluids, such as anesthetics and saline, to the space around the spinal cord.
Medicaid costs for a child's trip to an emergency room or clinic can be reduced annually by at least $198 per family when Head Start parents are provided with easy-to-understand health-care guidance, according to a first-of-its kind study by the UCLA/Johnson & Johnson Health Care Institute.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Louisa Gayle Chavez, MD 203 Hospital Dr, Raton, NM 87740-2012 Ph: (575) 445-3661 | Louisa Gayle Chavez, MD 203 Hospital Dr, Raton, NM 87740-2012 Ph: (575) 445-3661 |
News Archive
After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.
The continuous improvement of imaging technology holds great promise in areas where visual detection is necessary, such as with cancer screening. Three-dimensional imaging in particular has become popular because it provides a more complete picture of the target object and its context.
New research from Johns Hopkins suggests that it may not be the steroids in spinal shots that provide relief from lower back pain, but the mere introduction of any of a number of fluids, such as anesthetics and saline, to the space around the spinal cord.
Medicaid costs for a child's trip to an emergency room or clinic can be reduced annually by at least $198 per family when Head Start parents are provided with easy-to-understand health-care guidance, according to a first-of-its kind study by the UCLA/Johnson & Johnson Health Care Institute.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.
› Verified 7 days ago
Dr. Charles Leslie Secora, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 166 Hospital Dr, Raton, NM 87740 Phone: 505-445-4111 Fax: 505-445-2666 | |
Dr. Jameela Bai Tiku, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 130 S 3rd St, Raton, NM 87740 Phone: 575-445-5548 Fax: 575-445-5560 | |
Dr. Jessica L Roberts, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 203 Hospital Dr, Raton, NM 87740 Phone: 575-445-3661 |